Compounds > lenalidomide
Page last updated: 2024-09-05

lenalidomide and Eosinophilia, Tropical

lenalidomide has been researched along with Eosinophilia, Tropical in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (71.43)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Alfano, G; Ascione, E; Cazzato, S; Fontana, F; Leonelli, M; Maccaferri, M; Magistroni, R1
Osada, SI; Sato, T1
Chan, TSY; Kwong, YL; Mak, V1
Collado-Borrell, R; Escudero-Vilaplana, V; González-Arias, E; Osorio-Prendes, S; Sanjurjo-Sáez, M1
Nohgawa, M; Oka, S; Ono, K1
Dote, S; Hira, D; Itakura, S; Ito, K; Kobayashi, Y; Noda, S; Terada, T; Yamada, S; Yasu, T1
Baiocchi, OCCG; Batista, MD; Enokihara, MMSES; Gomes, EE; Sato-Sano, M; Teixeira, SP; Vargas, JC1

Reviews

1 review(s) available for lenalidomide and Eosinophilia, Tropical

ArticleYear
Drug-induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms Caused by Lenalidomide: Case Report and Review of the Literature.
    Acta dermato-venereologica, 2021, May-28, Volume: 101, Issue:5

    Topics: Drug Hypersensitivity Syndrome; Eosinophilia; Humans; Lenalidomide; Pharmaceutical Preparations

2021

Other Studies

6 other study(ies) available for lenalidomide and Eosinophilia, Tropical

ArticleYear
Skin reaction with Eosinophilia and Systemic Symptoms after lenalidomide in peritoneal Dialysis.
    Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2022, Oct-31, Volume: 39, Issue:5

    Topics: Aged; Drug Hypersensitivity Syndrome; Eosinophilia; Humans; Lenalidomide; Male; Peritoneal Dialysis

2022
Complete radiologic and molecular response of HIV-negative primary effusion lymphoma with short-course lenalidomide.
    Annals of hematology, 2017, Volume: 96, Issue:7

    Topics: Aged, 80 and over; DNA, Viral; Drug Eruptions; Drug Monitoring; Eosinophilia; Epstein-Barr Virus Infections; Gastrointestinal Stromal Tumors; Herpesvirus 4, Human; Humans; Immunologic Factors; Lenalidomide; Lymphoma, Primary Effusion; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Radiography, Thoracic; Treatment Outcome; Tumor Burden

2017
Eosinophilia secondary to lenalidomide therapy.
    Journal of clinical pharmacy and therapeutics, 2018, Volume: 43, Issue:2

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Hormonal; Cyclophosphamide; Dexamethasone; Eosinophilia; Female; Humans; Lenalidomide; Middle Aged; POEMS Syndrome; Thalidomide

2018
Multiple myeloma presenting as cutaneous leukocytoclastic vasculitis and eosinophilia disclosing a T helper type 1/T helper type 2 imbalance: a case report.
    Journal of medical case reports, 2018, Oct-31, Volume: 12, Issue:1

    Topics: Aged, 80 and over; Bortezomib; Eosinophilia; Female; Humans; IgA Vasculitis; Immunologic Factors; Lenalidomide; Multiple Myeloma; Paraneoplastic Syndromes; Th1 Cells; Th2 Cells; Treatment Outcome; Vasculitis, Leukocytoclastic, Cutaneous

2018
Impact of prior bortezomib therapy on the incidence of lenalidomide-induced skin rash in multiple myeloma: a propensity score-matched multi-institutional cohort study.
    Leukemia & lymphoma, 2019, Volume: 60, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cohort Studies; Disease Susceptibility; Eosinophilia; Exanthema; Female; Humans; Incidence; Lenalidomide; Male; Multiple Myeloma; Propensity Score

2019
Lenalidomide in the management of eosinophilic dermatosis of hematological malignancy.
    The Journal of dermatology, 2019, Volume: 46, Issue:7

    Topics: Eosinophilia; Exanthema; Humans; Lenalidomide; Lymphoma, Mantle-Cell; Male; Middle Aged; Paraneoplastic Syndromes; Pruritus; Skin; Treatment Outcome

2019